Antibiotic prophylaxis for temporary transvenous pacemakers.
D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001412:Bacillus subtilis / Q000302:isolation & purification; D006328:Cardiac Catheterization / Q000009:adverse effects*; D002512:Cephalothin / Q000627:therapeutic use; D004009:Dicloxacillin / Q000627:therapeutic use; D004754:Enterobacter / Q000302:isolation & purification; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D006801:Humans; D017053:Infection Control; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008712:Methicillin / Q000627:therapeutic use; D008875:Middle Aged; D010138:Pacemaker, Artificial / Q000009:adverse effects; D010406:Penicillins / Q000627:therapeutic use; D012867:Skin / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification; D013307:Streptomycin / Q000627:therapeutic use; D013997:Time Factors; D014556:Urine / Q000382:microbiology; D014680:Veins
D000900:Anti-Bacterial Agents; D010406:Penicillins; D007612:Kanamycin; D000667:Ampicillin; D004009:Dicloxacillin; D008712:Methicillin; D002512:Cephalothin; D013307:Streptomycin